Join us for CVI’s Inaugural Spotlight CME Program: “Meet the Experts: A Discussion on Recognizing and Treating Severe Hypercholesterolemia and High Triglycerides” for Physicians, Advanced Practice and all Allied Healthcare Professionals. Live webinar will be held:
Wednesday April 21, 2021 (3.25 Credits)
- 3.25 CME/CEU Credits
The CVI Inaugural Spotlight features an outstanding diverse faculty of national thought leaders including, Dr. Mary McGowan and Dr. Zahid Ahmad. It also features regional experts providing the most relevant and up-to-date information on recognizing and treating severe hypercholesterolemia and high triglycerides. Joining the other experts will be Genetic Counselor, Stephanie Asher and Patient Advocates Brian Tye and Darlene Voll who will share their personal and poignant experiences.
Familial Hypercholesterolemia (FH)
Approximately every 1 in 250 individuals is affected by FH making it one of the most common genetic conditions that if left untreated could lead to heart attacks, strokes, and poor cardiovascular outcomes. Based on recent finding, FH is often underdiagnosed and untreated in the general population. FH, while manageable, early diagnosis and treatment are integral to improve clinical cardiovascular outcomes in this population.
Hypertriglyceridemia contributes to the development and progression of atherosclerotic disease, yet triglycerides have a less prominent role in determining cardiovascular risk and are often overlooked by clinicians. As studies continue to evaluate the effectiveness of therapeutic options, healthcare providers need to know what available treatments to employ in patients whose triglyceride levels remain elevated despite optimized statin therapy.
Physicians, advanced practice providers, nurses, fellows and residents, and all healthcare professionals who participate in the care of patients with cardiovascular disease, particularly those with a specific interest in severe lipid disorders
Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by the Pennsylvania Medical Society are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationship(s) related to the content of their presentation(s).